MedPath

Safety confirmation test by continuous intake of test food on Healthy Adult Males and Females.

Not Applicable
Conditions
o
Registration Number
JPRN-UMIN000052719
Lead Sponsor
TES Holdings Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) Individuals using medical products. 2) Individuals who are patient or have a history of psychiatric disease, sleep disorder, high blood pressure, diabetes and hyperlipidemia. 3) Individuals who used a drug to treat a disease in the past 1 month (except temporal usage for pollenosis). 4) Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease. 5) Individuals who are a patient or have a history of or endocrine disease. 6) Individuals whose BMI is less than 18.5kg/m2 and over 30kg/m2. 7) Individuals whose systolic and diastolic blood pressures are over 140mmHg and 90mmHg, respectively and pulse rate of 85 beats/min or higher. 8) Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months. 9) Individuals who experienced unpleasant feeling during blood drawing. 10) Individuals with drug (including alcohols) and food allergies. 11) Individuals who habitually take the foods for specified health uses (FOSHU) or functional food (except for subjects who can stop consume them after informed consent). 12) Individuals who excessively take alcohol (expressed in an amount of alcohol: over 30g/day). 13) Individuals with possible changes of life style, such as conducting a long-term travel, during the test period. 14) Individuals who are pregnant, lactating, or who may become pregnant during the test period. 15) Individuals who participated in other clinical studies in the past 3 months. 16) Individuals who are or whose family is engaged in functional foods or cosmetics. 17) Individuals judged inappropriate for the study by the principal.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath